Back

Evolution of echocardiographic parameters during tafamidis therapy in patients with transthyretin cardiac amyloidosis: a real-world cohort study

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Valvular disease, diastolic function, atrioventricular coupling, and beyond Systolic and Diastolic Function ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

6 More presentations in this session

Presentation thumbnail
Left atrial–left ventricular coupling index as a novel diagnostic and prognostic marker in HFpEF: systematic review and meta-analysis
Doctor C. Fischer Bacca (Rio do Sul, BR)
Abstract Slides
Presentation thumbnail
Prognostic role of the left atrioventricular coupling index in patients with aortic regurgitation
Doctor M. Rojas (Santiago, CL)
Abstract Slides
Presentation thumbnail
Changes in diastolic function after TAVI: trends in conventional parameters and the role of left atrial reservoir strain
Doctor E. Eerola (Uppsala, SE)
Abstract Slides
Presentation thumbnail
Beyond the two cusps: disparities in echocardiographic assessment and guideline adherence in bicuspid aortic valve management in Argentina
Doctor M. Carrero (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Epicardial adipose tissue thickness measured by echocardiography is associated with metabolic syndrome in a surgical cohort of patients with coronary artery disease and valvular heart disease
Mr F. Opdahl (Oslo, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Valvular disease, diastolic function, atrioventricular coupling, and beyond

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Longitudinal changes in amyloid burden as measured by extracellular volume (ECV) on cardiac MRI for patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM)
28 August 2026
thumbnail
Congress Presentation
Effect of TTR stabilisers on strain values derived by echocardiography in patients with wild type ATTR Amyloidosis
18 May 2025
thumbnail
Congress Presentation
Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis
31 August 2025
thumbnail
Congress Presentation
Effect of tafamidis on left atrial function in patients with transthyretin amyloid cardiomyopathy
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources